Showing results (191-200 of 291) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injuryE H Ohlstein, S A Douglas, C P Sung, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptorJ A Lee, J D Elliott, J A Sutiphong, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone ratsF C Barone, A H Nelson, E H Ohlstein, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083S A Douglas, P Nambi, M Gellai, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonistE H Ohlstein, P Nambi, A Lago, et al.
The American Journal of Physiology|May 1, 1993
Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic ratsY X Wang, D P Brooks, R M Edwards
ANZ Journal of Surgery|November 9, 2019
How to do a simplified Dacron sleeve technique of aortic anastomosisTovi Vo, Jason A Varzaly, James R M Edwards
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of the angiotensin II receptor antagonist, eprosartanR M Edwards, R R Ruffolo, D P Brooks
Pageof 30